Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-046005
Filing Date
2013-08-22
Accepted
2013-08-22 09:29:12
Documents
1
Period of Report
2013-08-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd388926.html 4  
1 PRIMARY DOCUMENT rrd388926.xml 4 2979
  Complete submission text file 0001181431-13-046005.txt   4340
Mailing Address 1 STULTS DRIVE PLAINSBORO NJ 08536
Business Address
CAUWENBERGH GEERT (Reporting) CIK: 0001285648 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54910 | Film No.: 131054202

Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations